Akava Therapeutics Inc.

CIK 1966649 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Akava Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Feb 19, 2026D0001966649-26-000001
Feb 21, 2025D0001966649-25-000001
Apr 23, 2024D0001966649-24-000001
Mar 3, 2023D0001966649-23-000001